# Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)

> **NCT02114957** · EARLY_PHASE1 · COMPLETED · sponsor: **Texas Tech University Health Sciences Center** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** 800mg dietary supplement CognIQTM (4 capsules) by oral at hour 0

## Key facts

- **NCT ID:** NCT02114957
- **Lead sponsor:** Texas Tech University Health Sciences Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-04
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114957, "Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02114957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*